COMMUNIQUÉS West-GlobeNewswire

Tetraphase Pharmaceuticals Appoints Larry Tsai, M.D. to Chief Medical Officer
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
Tetraphase Pharmaceuticals Announces Submission of New Drug Application to FDA for Eravacycline for the Treatment of Complicated Intra-Abdominal Infections (cIAI)
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
Supernus to Present at the 2018 J.P. Morgan Healthcare Conference
02/01/2018
ROCKVILLE, Md., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central [...]
Five Prime Therapeutics Initiates Patient Dosing in Phase 1 Lead-In to Phase 3, Global Registrational Trial of FPA144 in Front-Line Advanced Gastric Cancer
02/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Envigo to Present at the 36th Annual JPMorgan Conference
02/01/2018
EAST MILLSTONE, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Envigo , a leading provider of nonclinical contract research services and research models, today announced that Adrian Hardy, Chief Executive Officer, and Patricia [...]
Update on progress in cystic fibrosis programs
02/01/2018
Positive results with FLAMINGO study C1 corrector GLPG2222 as monotherapy in homozygous Class II F508del CF patients Study over-recruited within 5 months in the US and Europe GLPG2222 was well tolerated when dosed once [...]
Opiant Pharmaceuticals Receives Approximately $5.3 Million of Cash from Exercise of Outstanding Warrants
02/01/2018
SANTA MONICA, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT ), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced [...]
CymaBay Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
NEWARK, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY ), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]
pSivida to Present at the Annual Biotech Showcase Conference
02/01/2018
WATERTOWN, Mass., Jan. 02, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug delivery products, announced today that Nancy Lurker, President and [...]
Trevena Announces FDA Acceptance for Review of New Drug Application for OLINVO™ (oliceridine) Injection
02/01/2018
CHESTERBROOK, Pa., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN ) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Company’s New Drug Application (NDA) for OLINVO™ ( [...]
Lexicon Pharmaceuticals Announces Poster Presentation at ASCO GI
02/01/2018
THE WOODLANDS, Texas, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), announced today that data from a poster highlighting XERMELO ® (telotristat ethyl) will be presented at the upcoming [...]
Atara Biotherapeutics Announces Proposed Offering of Common Stock
02/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]
Mesa Labs Declares Quarterly Dividend
02/01/2018
Lakewood, CO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB ) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0. [...]
Elite Pharmaceuticals Announces FDA Approval of Phendimetrazine Tartrate Tablets USP
02/01/2018
NORTHVALE, N.J., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
Transactions concluded by management
02/01/2018
Olaine, 2018-01-02 16:47 CET (GLOBE NEWSWIRE) -- AS Olainfarm has received the notification of manager on transactions with securities issued by AS Olainfarm. The received notification is available in attachment. [...]
American Health Council’s Honors Charles Tucker DNP, MSN, RN, CNE as “Best in Nursing”
02/01/2018
NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- The American Health Council honors accomplished clinician and Associate Professor of Nursing Charles Tucker DNP, MSN, RN, CNE as one of America’s “Best in Nursing.” Dr. Tucker [...]
Hemispherx Biopharma CEO Discusses 2017 Highlights on CEOLIVE.TV
02/01/2018
ORLANDO, Fla., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB), based in Orlando, FL, focused on pharmaceuticals, today announced that Thomas K. Equels, M.S. J.D., Chief Executive [...]
AIT Therapeutics Appoints Yoori Lee to its Board of Directors
02/01/2018
Seasoned veteran with decades of strategic, scientific, clinical and leadership experience NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused [...]
UroGen Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference
02/01/2018
RA’ANANA, Israel and NEW YORK, Jan. 02, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ: URGN ), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with [...]

Pages